この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2012/8/31 分で読めます
Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT); Public Workshop
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research is announcing a 4-day public workshop entitled "Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT)." The purpose of this workshop is to provide a forum to consider issues related to endpoints that can support drug development in the following disease areas: Eosinophilic esophagitis, pediatric and adult inflammatory bowel disease, and parenteral nutrition-associated liver disease.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →